Nuclear Medicine: Page 307

Covidien to move HQ to Ireland

By AuntMinnie.com staff writers

The parent company of radiopharmaceutical firm Covidien has set in motion plans to incorporate in Ireland and relocate its executive office from Hamilton, Bermuda.

January 6, 2009

NRC initiates tracking system

By AuntMinnie.com staff writers

The U.S. Nuclear Regulatory Commission (NRC) has deployed its National Source Tracking System to account for high-risk radioactive materials used in industry, medicine, and research.

January 6, 2009

PET-based F-18 FLT equivocal for leukemia imaging

By Wayne Forrest

Researchers in Germany and the U.S. hoped that switching radiopharmaceuticals from FDG might improve PET's performance for imaging leukemia. While they found some benefits to using the new tracer, they also discovered some shortcomings.

January 6, 2009

Medrad sponsors Swiss PET project

By AuntMinnie.com staff writers

Contrast injector technology firm Medrad signed a research agreement with the University of Zurich to study dynamic PET imaging with the Medrad Intego PET infusion system.

January 5, 2009

SPECT/CT outdoes planar imaging with lymph nodes

By Wayne Forrest

A newly released study in this month's issue of the Journal of Nuclear Medicine has found that SPECT/CT is better than planar imaging in accurately determining lymph node involvement at radioablation performed for thyroid cancer.

January 4, 2009

Molecular Insight completes phase II trial for Zemiva

By AuntMinnie.com staff writers

Radiopharmaceutical developer Molecular Insight Pharmaceuticals has completed a phase II clinical trial for its chest imaging agent Zemiva.

December 22, 2008